Download PDF
Thromb Haemost 2004; 91(06): 1258-1259
DOI: 10.1055/s-0037-1614267
Letters to the Editor
Schattauer GmbH

Hemochromatosis gene (HFE) polymorphisms are not associated with peripheral arterial disease

Herwig Köppel
,
Peter Krippl
,
Robert Gasser
,
Thomas C. Wascher
,
Bernhard Paulweber
,
Ernst Pilger
,
Wilfried Renner
Further Information

Publication History

Received 27 February 2004

Accepted 16 March 2004

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Meyers DG. The iron hypothesis-does iron cause atherosclerosis?. Clin Cardiol 1996; (19) 925-9.
    PubMedGoogle Scholar
  • 2 McCord JM. Effects of positive iron status at a cellular level. Nutr Rev 1996; (54) 85-8.
    PubMedGoogle Scholar
  • 3 Corti MC, Gaziano M, Hennekens CH. Iron status and risk of cardiovascular disease. Ann Epidemiol 1997; (07) 62-8.
    PubMedGoogle Scholar
  • 4 Datz C, Haas T, Rinner H. et al. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency?. Clin Chem 1998; 44: 2429-32.
    PubMedGoogle Scholar
  • 5 Gaenzer H, Marschang P, Sturm W. et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 40 (12) 2189-94.
    CrossrefPubMedGoogle Scholar
  • 6 Lekakis J, Papamicheal C, Stamatelopoulos K. et al. Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis. Vase Med 1999; 04 (03) 147-8.
    PubMedGoogle Scholar
  • 7 Salonen JT, Nyyssonen K, Korpela H. et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-11.
    CrossrefPubMedGoogle Scholar
  • 8 Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 331: 1159.
    CrossrefPubMedGoogle Scholar
  • 9 Roest M, van der Schouw YT, de Valk B. et al. Heteroziguosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999; 100: 1268-73.
    CrossrefPubMedGoogle Scholar
  • 10 Rasmussen ML, Folsom AR, Catellier DJ. et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerotic Risk in Communities (ARIC) study. Atherosclerosis 2001; 154 (03) 739-46.
    CrossrefPubMedGoogle Scholar
  • 11 Renner W, Pabst E, Paulweber B. et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for arterial disease. Atherosclerosis 2002; 165 (01) 175-8.
    CrossrefPubMedGoogle Scholar
  • 12 Sanchez LA, Veith FJ. Diagnosis and treatment of chronic lower extremity ischemia. Vase Med 1998; (03) 291-9.
    PubMedGoogle Scholar